Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

Shield Therapeutics secures $10m investment, announces RetailBook offer
6 Dec 2024

Shield Therapeutics secures $10m investment, announces RetailBook offer

(Sharecast News) - Shield Therapeutics announced on Friday that it has secured a $10m investment from its largest shareholder, AOP Health Internationa...

Shield Therapeutics shares up on strong October sales
21 Nov 2024

Shield Therapeutics shares up on strong October sales

(Alliance News) - Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following strong sales of...

Shield Therapeutics shares slide as it expands financing arrangement
29 Oct 2024

Shield Therapeutics shares slide as it expands financing arrangement

(Alliance News) - Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flow positive by t...

Shield Therapeutics reports strong quarter for Accrufer
29 Oct 2024

Shield Therapeutics reports strong quarter for Accrufer

(Sharecast News) - Shield Therapeutics reported a strong third-quarter performance for its iron deficiency treatment Accrufer in the US on Tuesday, ac...

Shield Therapeutics announces promising paediatric trial results
25 Sep 2024

Shield Therapeutics announces promising paediatric trial results

(Sharecast News) - Shield Therapeutics announced promising results from its phase three paediatric clinical trial for 'Accrufer' and 'Ferracru', or fe...

LONDON MARKET MIDDAY: FTSE 100 remains red ahead of US data
4 Sep 2024

LONDON MARKET MIDDAY: FTSE 100 remains red ahead of US data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, despite positive service sector data, as the market continued to process a...

Shield Therapeutics revenue triples, but cost rises widen annual loss
4 Sep 2024

Shield Therapeutics revenue triples, but cost rises widen annual loss

(Alliance News) - Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales after its US exp...

AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade
4 Sep 2024

AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.